TBET — Tibet Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Tibet Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 5.93 | 9.24 | 13.1 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 0 | 0.158 | 0.009 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.533 | 0.043 | -6.2 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Cash from Operating Activities | 6.19 | 10.3 | 7.85 |
| Capital Expenditures | -0.642 | 0 | -0.15 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.642 | 0 | -0.15 |
| Financing Cash Flow Items | -0.138 | -0.187 | 1.56 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -4.38 | -8.97 | -4.56 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 1.3 | 1.37 | 3.5 |